|
English
|
正體中文
|
简体中文
|
2823024
|
|
???header.visitor??? :
30244739
???header.onlineuser??? :
953
???header.sponsordeclaration???
|
|
|
???tair.name??? >
???browser.page.title.author???
|
"stanciu c"???jsp.browse.items-by-author.description???
Showing items 1-1 of 1 (1 Page(s) Totally) 1 View [10|25|50] records per page
國立臺灣大學 |
2013 |
ALISPORIVIR (ALV) PLUS PEGINTERFERON/RIBAVIRIN (PR) ACHIEVES HIGH SVR12 RATES AMONG NULL RESPONDERS, IL28BCT/TT AND CIRRHOTIC HCVG1 PATIENTS (FUNDAMENTAL STUDY INTERIM ANALYSIS)
|
Buti, M.; Flisiak, R.; Rasenack, J.; Davis, G.; Alberti, A.; Goeser, T.; Stanciu, C.; Chuang, W. -L.; Tabak, F.; Kao, J. -H.; Streinu-Cercel, A.; Hofstetter, G.; Wang, J.; Avila, C.; Orsenigo, R.; 高嘉宏 |
Showing items 1-1 of 1 (1 Page(s) Totally) 1 View [10|25|50] records per page
|